Krystal Biotech Inc (KRYS)

Return on assets (ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	89,159	10,932	-139,975	-69,570	-32,167
Total assets	US$ in thousands	1,055,840	818,355	558,450	626,295	310,844
ROA		8.44%	1.34%	-25.06%	-11.11%	-10.35%

December 31, 2024 calculation

ROA = Net income ÷ Total assets
= $89,159K ÷ $1,055,840K
= 8.44%

The return on assets (ROA) for Krystal Biotech Inc has shown significant fluctuations over the years. In December 31, 2020 and December 31, 2021, the ROA was in negative territory, indicating that the company was generating a negative return on its assets during those periods. The ROA deteriorated further to -25.06% on December 31, 2022, suggesting a significant decline in the company's ability to generate profits relative to its assets.

However, there was a notable turnaround in the company's performance as of December 31, 2023, with the ROA improving to 1.34%, indicating a positive return on assets for the period. This positive trend continued into December 31, 2024, where the ROA increased to 8.44%, reflecting a further improvement in the company's profitability relative to its asset base.

Overall, the fluctuating trend in Krystal Biotech Inc's return on assets highlights the company's varying ability to generate profits from its assets over the years. The recent positive performance indicates a potential turnaround in the company's profitability and efficiency in utilizing its assets effectively. Further monitoring of the ROA will be crucial to assess the sustainability of this positive trend in the company's financial performance.